Companies that do not have an effective document control system run the risk of failing to meet the regulatory requirements of the FDA, CE and other international compliance bodies. As an added pain point, failure to comply can result in the FDA issuing a 483 observation, a notice which both highlights the potential regulatory violations observed during an inspection and shines an unwelcome spotlight on the failures in quality management processes.